|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
00348 CHINAHEALTHWISE
Nominal 
0.092 0.000 (0.000%) | 2025/12 - Final HKD(K$) | %Chg (Compare to Final) | 2024/12 HKD(K$) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | |
| Turnover | 99,564 | -12.336% | 113,575 | 146,317 | 142,058 | 170,079 |
| Cost of Sales | (66,102) | -13.282% | (76,226) | (86,023) | (88,788) | (79,085) |
| Gross Profit | 33,462 | -10.407% | 37,349 | 60,294 | 53,270 | 90,994 |
| 2025/12 - Final HKD(K$) | %Chg (Compare to Final) | 2024/12 HKD(K$) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | (216) | |
| Change in FV & Impairment on Others | 2,309 | -- | (3,146) | (107,790) | (25,406) | (105,629) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | (3,292) | -91.776% | (40,028) | (132,059) | (56,401) | (100,580) | |
| Taxation | 686 | -- | (253) | (2,499) | 2,127 | (2,466) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 0 | -- | 0 | 0 | 0 | 0 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (2,606) | -93.530% | (40,281) | (134,558) | (54,274) | (103,046) | |
| 2025/12 - Final HKD(K$) | %Chg (Compare to Final) | 2024/12 HKD(K$) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | |
| Net Finance Costs / (Income) | 13,828 | 66.622% | 8,299 | 8,993 | 7,297 | 6,410 |
| Depreciation & Amortisation | 6,406 | -10.656% | 7,170 | 5,615 | 3,304 | 4,198 |
| Directors' Emoluments | 8,749 | -3.762% | 9,091 | 19,061 | 20,161 | 15,609 |
| 2025/12 - Final | %Chg (Compare to Final) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Auditor's Opinion Status | Unqualified (Modified Report) | -- | Unqualified (Modified Report) | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2025/12 - Final | %Chg (Compare to Final) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| EPS (cts) | -0.340 | -93.499% | -5.230 | -17.460 | -7.040 | -13.370 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | 0.004 | 0.019 | (0.037) | 0.055 |
| NBV per share ($) | (0.027) | -- | (0.024) | 0.006 | 0.180 | 0.251 |
| Remarks: | Real time quote last updated: 01/04/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K$) | HKD -2,606 |
| %Change | -93.530% |
| EPS / (LPS) | HKD -0.003 |
| NBV Per Share ($) | HKD -0.027 |